Related Experiment Video
Updated: Apr 27, 2026

Quantified Assessment of Infant's Gross Motor Abilities Using a Multisensor Wearable
Published on: May 17, 2024
The Neuro-Sensory Motor Developmental Assessment Part II: Predictive and Concurrent Validity
Insights
The Neuro-sensory Motor Developmental Assessment (NSMDA) effectively tracks infant development. The study found 8 months to be the optimal age for using NSMDA to predict neurodevelopmental outcomes in preterm infants.
Area of Science:
- Developmental Pediatrics
- Neuroscience
- Infant Assessment Tools
Background:
- A progressive evaluation tool for infants and children was needed.
- The Neuro-sensory Motor Developmental Assessment (NSMDA) was developed to address this need.
- Part One of this paper detailed the NSMDA's content and administration.
Purpose of the Study:
- To provide statistical evidence for the validity of the NSMDA.
- To verify the NSMDA's predictive and concurrent validity.
- To assess the optimal age for NSMDA use in predicting developmental outcomes.
Main Methods:
- The NSMDA was administered to 148 preterm infants at 1, 4, 8, 12, and 24 months.
- Developmental outcomes were assessed at 24 months.
- Statistical analyses were performed to evaluate validity and identify optimal assessment ages.
Main Results:
- Early NSMDA scores showed significant correlation with 24-month developmental outcomes.
- The NSMDA demonstrated predictive validity (sensitivity/specificity) and concurrent validity.
- The 8-month assessment was the most effective for discriminating normal versus abnormal developmental status.
Conclusions:
- The NSMDA is a valid tool for assessing neuro-sensory motor development in infants.
- The 8-month NSMDA assessment provides the optimal window for predicting long-term developmental trajectories in preterm infants.
- This study supports the use of the NSMDA for early identification of developmental concerns.
Abstract:
The Neuro-sensory Motor Developmental Assessment (NSMDA) has been developed to meet the need for a progressive evaluation of infants and children. The content and administration of the NSMDA has been addressed in Part One of this paper. In this study the NSMDA was used to assess a cohort of 148 preterm infants at 1, 4, 8, 12, and 24 months. Results recorded at each assessment were compared with developmental outcome at 24 months. This paper provides statistical evidence of the NSMDA's validity. Verification in terms of predictive validity (sensitivity/specificity), and concurrent validity is described. Although early NSMDA scores were significantly correlated with outcome at two years, 8 months was found to be the optimal age for accurately discriminating between children who demonstrated normal or abnormal developmental status.

